Replies to post #448379 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Do you understand what it means when EMA says:

Overall, the assessment of a new medicine usually lasts around a year.

Or are you simply ignoring it for convenience and in compliance with your PUMPER DUMPER script?

Also keep in mind that even if Anavex are granted the AA regulatory pathway there are still two clock-stops, where the company can take as long as they need to reply. Given the average assessment time last around a year, and will include AA reviews, there will generally always be CHMP review comments that require a response from the company.